Compare DNTH & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNTH | MD |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | N/A | 1995 |
| Metric | DNTH | MD |
|---|---|---|
| Price | $51.68 | $20.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $70.22 | $21.00 |
| AVG Volume (30 Days) | ★ 931.1K | 560.4K |
| Earning Date | 03-10-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | $3,078,000.00 | ★ $1,922,442,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.70 |
| P/E Ratio | ★ N/A | $11.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.37 | $11.84 |
| 52 Week High | $57.50 | $24.99 |
| Indicator | DNTH | MD |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 41.61 |
| Support Level | $48.86 | $20.25 |
| Resistance Level | $57.50 | $22.47 |
| Average True Range (ATR) | 3.13 | 0.71 |
| MACD | 0.51 | -0.09 |
| Stochastic Oscillator | 61.47 | 22.53 |
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.